Axa
ASMB icon

Axa’s Assembly Biosciences ASMB Stock Holding History

Axa’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-17,895
Closed -$3.53M – 1258
2020
Q3 		$3.53M Sell
17,895
-176
-1% -$44.3K 0.01% 716
2020
Q2 		$5.06M Buy
18,071
+897
+5% +$209K 0.02% 609
2020
Q1 		$3.06M Sell
17,174
-1,281
-7% -$275K 0.02% 646
2019
Q4 		$4.53M Sell
18,455
-3,254
-15% -$599K 0.02% 654
2019
Q3 		$2.56M Sell
21,709
-33
-0.2% -$4.99K 0.01% 811
2019
Q2 		$3.52M Buy
21,742
+402
+2% +$76.4K 0.01% 741
2019
Q1 		$5.04M Buy
21,340
+6,818
+47% +$1.73M 0.02% 644
2018
Q4 		$3.94M Hold
14,522
– – 0.02% 669
2018
Q3 		$6.47M Buy
14,522
+2,917
+25% +$1.37M 0.02% 600
2018
Q2 		$5.46M Buy
11,605
+1,860
+19% +$984K 0.02% 632
2018
Q1 		$5.75M Sell
9,745
-104
-1% -$64.5K 0.02% 614
2017
Q4 		$5.35M Sell
9,849
-11
-0.1% -$4.98K 0.02% 632
2017
Q3 		$4.13M Sell
9,860
-135
-1% -$41.4K 0.02% 665
2017
Q2 		$2.48M Buy
+9,995
New +$2.81M 0.01% 750

Other funds holding ASMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Axa's ASMB Position: Q4 2020 in Review

Axa sold out of Assembly Biosciences (ASMB) in Q4 2020, closing a stake of 17,895 shares — an estimated $3.53M sold.

Axa first reported a position in ASMB in Q2 2017 and held it in 14 quarters. The position peaked at $6.47M in Q3 2018. 109 funds tracked by Wall St. Rank hold ASMB as of Q4 2020.

  • Axa reported no remaining Assembly Biosciences position as of Q4 2020 after selling out during the quarter.
  • Axa sold 17,895 Assembly Biosciences shares in Q4 2020, an estimated $3.53M.
  • Axa first reported a position in Assembly Biosciences in Q2 2017 and held it in 14 quarters.
  • Axa's Assembly Biosciences position peaked at $6.47M in Q3 2018.
  • 109 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2020.

Based on Axa's 13F filing for Q4 2020, filed 12 Feb 2021.